WHAT'S TISCH? RESEARCH STEM CELL TRIAL NEWS TEAM TISCH GET INVOLVED SEARCH DONATE Publications Mesenchymal stem cell-derived neural progenitors in progressive MS Publication Date January 19, 2021 Publication Information Violaine K. Harris, PhD, James W. Stark, MD, FAAN, Sophia Yang, BA, Shayna Zanker, BS, John Tuddenham, BA, and Saud A. Sadiq, MD, FAAN READ PUBLICATION Safety of long-term intrathecal methotrexate in progressive forms of MS Publication Date December 3, 2019 Publication Information Stark J, Josephs L, Dulak D, Clague M, and Sadiq SA. Therapeutic Advances in Neurological Disorders. 2019; 12: 1756286419892360. READ PUBLICATION Phase I Trial of Intrathecal Mesenchymal Stem Cell-derived Neural Progenitors in Progressive Multiple Sclerosis Publication Date February 1, 2018 Publication Information Harris VK, Stark J, Vyshkina T, Blackshear L, Joo G, Stefanova V, Sara G, and Sadiq SA. EBioMedicine. 2018; 29: 23-30. READ PUBLICATION Adenosine A2A receptor agonist ameliorates EAE and correlates with Th1 cytokine-induced blood brain barrier dysfunction via suppression of MLCK signaling pathway Publication Date October 12, 2017 Publication Information Liu Y, Alahiri M, Ulloa B, Xie B, and Sadiq SA. Immunity, Inflammation, and Disease. 2018; 6(1): 72-80. REQUEST FULL TEXT Fetuin-A deficiency protects mice from Experimental Autoimmune Encephalomyelitis (EAE) and correlates with altered innate immune response. Publication Date April 7, 2017 Publication Information Harris VK, Bell L, Langan RA, Tuddenham J, Landy M, and Sadiq SA. PLoS One. 2017; 12(4): e0175575. READ PUBLICATION Biomarkers of multiple sclerosis: current findings. Publication Date January 12, 2017 Publication Information Harris VK, Tuddenham JF, and Sadiq SA. Degenerative Neurological and Neuromuscular Disease. 2017; 7: 19-29. READ PUBLICATION Transglutaminase-6 is an autoantigen in progressive multiple sclerosis and is upregulated in reactive astrocytes Publication Date December 22, 2016 Publication Information Cristofanilli M, Gratch D, Pagano B, McDermott K, Huang J, Jian J, Bates D, and Sadiq SA. Mult Scler. 2017; 23(13): 1707-1715. REQUEST FULL TEXT Clinical safety of intrathecal administration of mesenchymal stromal cell-derived neural progenitors in multiple sclerosis. Publication Date December 1, 2016 Publication Information Harris VK, Vyshkina T, and Sadiq SA. Cytotherapy. 2016;18(12): 1476-1482. REQUEST FULL TEXT Stem cell therapy in multiple sclerosis: a future perspective Publication Date June 1, 2015 Publication Information Harris VK, and Sadiq SA. Stem cell therapy in multiple sclerosis: a future perspective. Neurodegenerative Disease Management. 2015; 5(3):167-170. READ PUBLICATION Biomarkers of Therapeutic Response in Multiple Sclerosis: Current Status Publication Date December 1, 2014 Publication Information Harris VK, and Sadiq SA. Mol Diagn Ther. 2014; 18(6): 605-617. READ PUBLICATION Pages 1 2 3 4 next › last » IN THIS SECTION Laboratory Repair the Damage with Stem Cells Understand Disease Progression Discover the Cause of MS Translate the Research to Patients Publications Abstracts Tisch MS Research Center of New York 521 West 57th Street 4th Floor New York, NY 10019 (646) 557-3900 Privacy Policy Tisch MS News Tisch MSRCNY Holiday Closing Research Priorities at Tisch MSRCNY Happy Veterans Day! More » Support Tisch MS Support Tisch MS and our innovative research leading to treatments that improve the lives of patients. DONATE Safe & Secure This is the website of the Tisch MS Research Center of New York, a non-profit, 501(c)(3), independent, multiple sclerosis research center, and not a medical practice. CLICK HERE to be directed to our clinical affiliate, the International Multiple Sclerosis Management Practice. 521 West 57 St., 4th Flr, NY, NY 10019 | ©2017 Tisch MS All rights reserved. We use cookies on this site to enhance your user experience By clicking the Accept button, you agree to us doing so. No, give me more info OK, I agree